1h Free Analyst Time
The blood-grouping reagents market is forecasted to grow by USD 520.68 mn during 2023-2028, accelerating at a CAGR of 8.13% during the forecast period. The report on the blood-grouping reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic disorders, rise in blood donations, and a growing number of hospitals and blood banks.
The blood-grouping reagents market is segmented as below:
By End-user
- Hospitals and blood banks
- Clinical laboratories
- Academic and research institutes
By Technique
- PCR-based and microarray techniques
- Assay-based techniques
- Massively parallel sequencing techniques
- Serology
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the blood-grouping reagents market covers the following areas:
- Blood-grouping reagents market sizing
- Blood-grouping reagents market forecast
- Blood-grouping reagents market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Technique
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global blood-grouping reagents market: AliveDX, Arena Bio Scien, ARKRAY Inc., Atlas Medical GmbH, BAG Health Care GmbH, Bio Rad Laboratories Inc., Calibre Scientific Inc., Danaher Corp., DIAGAST SAS, Grifols SA, Merck KGaA, Novacyt SA, QuidelOrtho Corp., Rapid Labs Ltd., Thermo Fisher Scientific Inc., Torax Biosciences Ltd., Tulip Diagnostics Pvt. Ltd., Fortress Diagnostics, Paragon Care Ltd., and VitroScient.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advancements in diagnostic devices."
According to the report, one of the major drivers for this market is the increasing prevalence of chronic disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AliveDX
- Arena Bio Scien
- ARKRAY Inc.
- Atlas Medical GmbH
- BAG Health Care GmbH
- Bio Rad Laboratories Inc.
- Calibre Scientific Inc.
- Danaher Corp.
- DIAGAST SAS
- Grifols SA
- Merck KGaA
- Novacyt SA
- QuidelOrtho Corp.
- Rapid Labs Ltd.
- Thermo Fisher Scientific Inc.
- Torax Biosciences Ltd.
- Tulip Diagnostics Pvt. Ltd.
- Fortress Diagnostics
- Paragon Care Ltd.
- VitroScient
